NexGel Inc (NXGL)
2.25
+0.05
(+2.27%)
USD |
NASDAQ |
May 02, 16:00
2.25
0.00 (0.00%)
After-Hours: 20:00
NexGel Cash from Investing (TTM): 4.456M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.456M |
| September 30, 2023 | 5.202M |
| June 30, 2023 | 4.326M |
| March 31, 2023 | -5.198M |
| December 31, 2022 | -5.595M |
| September 30, 2022 | -5.947M |
| June 30, 2022 | -5.404M |
| March 31, 2022 | -0.002M |
| December 31, 2021 | -0.269M |
| Date | Value |
|---|---|
| September 30, 2021 | -0.55M |
| June 30, 2021 | -0.503M |
| March 31, 2021 | -0.578M |
| December 31, 2020 | -0.312M |
| September 30, 2020 | -0.152M |
| June 30, 2020 | -0.076M |
| March 31, 2020 | -0.001M |
| December 31, 2019 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-5.947M
Minimum
Sep 2022
5.202M
Maximum
Sep 2023
-0.6237M
Average
-0.269M
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
| Anika Therapeutics Inc | -5.427M |
| The Cooper Companies Inc | -659.80M |
| Staar Surgical Co | 74.35M |
| OrthoPediatrics Corp | 41.68M |
| Innovative Eyewear Inc | -0.1988M |